Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.3.1 (
NADPH oxidase
)
11,281
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tributyltin chloride
(
TBT
) is an organotin compound that reduces estrogen levels in female rats. We aimed to investigate the effects of
TBT
exposure on vascular tonus and vascular remodelling in the resistance arteries of female rats. Rats were treated daily with
TBT
(500 ng/kg) for 15 days.
TBT
did not change arterial blood pressure but did modify some morpho-physiological parameters of third-order mesenteric resistance arteries in the following ways: (1) decreased lumen and external diameters; (2) increased wall/lm ratio and wall thickness; (3) decreased distensibility and increased stiffness; (4) increased collagen deposition; and (5) increased pulse wave velocity.
TBT
exposure increased the phenylephrine-induced contractile response in mesenteric resistance arteries. However, vasodilatation responses induced by acetylcholine and sodium nitroprusside were not modified by
TBT
. It is suggested that
TBT
exposure reduces vascular nitric oxide (NO) production, because:(1) L-NAME incubation did not cause a leftward shift in the concentration-response curve for phenylephrine; (2) both eNOS protein expression; (3) in situ NO production were reduced. Incubation with L-NAME; and (4) SOD shifted the phenylephrine response curve to the left in
TBT
rats. Tiron, catalase, ML-171 and VAS2870 decreased vascular reactivity to phenylephrine only in
TBT
rats. Moreover, increased superoxide anion production was observed in the mesenteric resistance arteries of
TBT
rats accompanied by an increase in gp91phox, catalase, AT1 receptor and total ERK1/2 protein expression. In conclusion, these findings show that
TBT
induced alterations are most likely due to a reduction of NO production combined with increased O2(-) production derived from
NADPH oxidase
and ERK1/2 activation. These findings offer further evidence that
TBT
is an environmental risk factor for cardiovascular disease.
...
PMID:Tributyltin chloride increases phenylephrine-induced contraction and vascular stiffness in mesenteric resistance arteries from female rats. 2687 47